Requip and Avastin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Requip (ropinirole hydrochloride) and Avastin (bevacizumab). Common drug interactions include vision blurred among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Requip and Avastin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Avastin?

Avastin has active ingredients of bevacizumab. It is often used in high blood cholesterol. eHealthMe is studying from 76,365 Avastin users. Check the latest studies of Avastin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

17 people who take Requip and Avastin together, and have interactions are studied.

What are the common drug interactions of Requip and Avastin, by gender? *:

female:

Vision blurred
Hypertension (high blood pressure)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain
Blindness
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Bone marrow disorder

male:

Death
Fatigue (feeling of tiredness)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Tremor (trembling or shaking movements in one or more parts of your body)
Dyspnoea (difficult or laboured respiration)
Haemoglobin decreased
Blood glucose increased
Dysphagia (a condition in which swallowing is difficult or painful)
Lip swelling
Vitreous floaters (spots before the eyes)

What are the common drug interactions of Requip and Avastin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood glucose increased
Fatigue (feeling of tiredness)
Vitreous floaters (spots before the eyes)
Death
Dyspnoea (difficult or laboured respiration)
Haemoglobin decreased
Pleural effusion (water on the lungs)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Back pain

60+:

Eyelid ptosis (falling of the upper or lower eyelid)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Lip swelling
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nausea (feeling of having an urge to vomit)
Vomiting
Dysaesthesia (abnormal sensation)
Amyloidosis (a tumour within which amyloid is produced)
Arteriosclerosis (thickening and hardening of arteries)
Atelectasis (partial or complete collapse of the lung)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 6 people, 35.29%
Stress And Anxiety: 5 people, 29.41%
Colon Cancer: 4 people, 23.53%
Parkinson's Disease: 3 people, 17.65%
Pain: 3 people, 17.65%
High Blood Pressure: 3 people, 17.65%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 2 people, 11.76%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 11.76%
Bladder Pain: 2 people, 11.76%
Constipation: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and Avastin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously